1;Preface;5 2;Contents;9 3;I Chronic Viral and Inflammatory Cardiomyopathy;18 3.1;1 Overview on Chronic Viral Cardiomyopathy/Chronic Myocarditis;19 3.2;2 Unsolved Medical Issues and New Targets for Further Research in Viral Myocarditis and Dilated Cardiomyopathy;35 4;II Viruses;52 4.1;3 Frontiers in Viral Diagnostics;53 4.2;4 Invited for Debate: Is Virus Persistence a Determinant for Disease Progression?;69 4.3;5 Parvovirus B19: The Causative Agent of Dilated Cardiomyopathy or a Harmless Passenger of the Human Myocard?;76 4.4;6 Parvovirus B19: A New Emerging Pathogenic Agent of Inflammatory Cardiomyopathy;96 4.5;7 Role of Hepatitis C Virus in Cardiomyopathies;111 5;III Immunity and Autoimmunity;133 5.1;8 Recent Insights into the Role of Host Innate and Acquired Immunity Responses;134 5.2;9 The Significance of Autoimmunity in Myocarditis;151 5.3;10 The Roles of Immunity and Autoimmunity in Chronic Heart Failure;165 5.4;11 Clinical Implications of Anti-cardiac Immunity in Dilated Cardiomyopathy;179 6;IV Cardiac Remodeling;204 6.1;12 Inflammation and Cardiac Remodeling During Viral Myocarditis;205 6.2;13 Inflammatory Cardiomyopathy: There Is a Specific Matrix Destruction in the Course of the Disease;227 6.3;14 Invited for Debate: Is There a Virus-Specific Matrix Destruction in the Course of Disease in Dilated Cardiomyopathy?;259 7;V Diagnosis and Treatment;266 7.1;15 New Non-invasive Approaches for the Diagnosis of Cardiomyopathy: Magnetic Resonance Imaging;267 7.2;16 New Therapeutics Targets in Chronic Viral Cardiomyopathy;292 7.3;17 Myocarditis and Inflammatory Cardiomyopathy: Histomorphological Diagnosis;309 7.4;18 Anti-viral Treatment in Patients with Virus-Induced Cardiomyopathy;326 7.5;19 Immunosuppressive Treatment of Chronic Non-viral Myocarditis;346